Sarah M. Bagley MD
Associate Professor, General Internal Medicine
Associate Professor, Adolescent Medicine
801 Massachusetts Ave | (617) 414-7399sarah.bagley@bmc.org
sbagley@bu.edu
Sections
General Internal Medicine
Centers
Clinical Addiction Research and Education Unit
Biography
Sarah Bagley is an Associate Professor of Medicine and Pediatrics at the Chobanian & Avedisian School of Medicine and is board certified in Pediatrics, Internal Medicine, and Addiction Medicine. She is the founder of the CATALYST at Boston Medical Center, a clinical program providing integrated substance use care and primary care for youth where she sees patients. Her passion is to ensure that all youth who use substances have access to high quality, equitable care to promote their health. Her research focus is on the engagement of young adults who use drugs and their families in care to minimize risk for overdose and the complications of drug use. She has funding from the National Institute on Drug Abuse, the Centers for Disease Control and Prevention, and PCORI to conduct research about engagement in treatment and overdose prevention of young adults after nonfatal opioid overdose and reducing stimulant related overdose.
Education
Medicine-Internal, MD, Georgetown University School of Medicine
Public Health - Epidemiology, MSc, Boston University School of Public Health
Classics, BA, Brown University
Publications
Goddard-Eckrich D, Chahine RA, Glasgow L, Oga E, Miles J, Holloway J, Hall ME, Bagley SM, Kim E, Davis A, Chassler D, D'souza N, Mack S, Davis J, Harness J, Lea CH, Bridden C, Herron N, Larimore E, Calver K, Salsberry P. Community coalition's diversity and targeted overdose prevention strategies designed to reach special populations. Harm Reduct J. 2026 May 18. PMID: 42151985.
Published on 5/5/2026Sharma A, Mita C, Dozier K, Singh R, Chukka A, Ramadas R, Taneja S, Batchelder A, Bagley SM, Thakur A, Sullivan MC, Sk SK, Solomon SS, Mayer KH, O'Cleirigh C, Hassan A, Ganapathi L. Family-centered interventions for people with substance use disorders in low-and middle-income country settings: a scoping review. Int J Drug Policy. 2026 Jul; 153:105298. PMID: 42091009.
Published on 4/21/2026Renehan CM, Alim AM, Cogan A, Wiggins M, Weinberger E, Carney BL, Alves J, Ventura AS, Day Lopes M, Bagley SM. Overdose Prevention Education and Medication for Opioid Use Disorder in School-Based Health Centers: A Qualitative Exploration. Subst Use Addctn J. 2026 Apr 21; 29767342261442454. PMID: 42015606.
Published on 4/20/2026Xuan Z, Walley AY, Formica SW, Wang J, Gamble MC, Kosakowski S, Murray S, Wiggins M, Cogan AG, Haley DF, Hyde J, Bagley SM. Impact of a stimulant-inclusive post-overdose outreach toolkit on engagement of overdose survivors who use stimulants: An interrupted time series analysis. Drug Alcohol Depend. 2026 Jun 01; 283:113129. PMID: 42014260.
Published on 3/17/2026Rapisarda SS, Silcox J, Fielman S, D'Ippolito M, Bagley SM, Green TC. Extending harm reduction through public health vending machines: Insights from implementation efforts in the United States. J Subst Use Addict Treat. 2026 Jul; 186:209944. PMID: 41850530.
Published on 12/1/2025Hadland SE, Kimmel SD, Yan S, Bettano AL, Lo-Ciganic WH, Bagley SM, Calihan JB, Hsu HE, Larochelle MR. Buprenorphine Treatment Duration and Adherence Among Youth and Subsequent Health Outcomes. Pediatrics. 2025 Dec 01; 156(6). PMID: 41248890.
Published on 11/26/2025Westerman CA, Nielsen K, Flynn D, Yule AM, Calihan JB, Hadland SE, Bagley SM. A Scoping Review of Clinical Trials Evaluating Medications for Adolescents With Substance Use Disorders. J Addict Med. 2025 Nov 26. PMID: 41481865.
Published on 11/20/2025Bagley SM, Maschke AD, Harris MTH, Walley AY, Johnson S, Hurstak E, Farley J, Keller SG, McMahan VM, Barrett C, Coffin PO, Gunn CM. A qualitative study exploring motivations for participating in research among women who use opioids. PLoS One. 2025; 20(11):e0336061. PMID: 41264582.
Published on 10/30/2025Chatterjee A, Chase RP, Chahine RA, Davis J, Dsouza N, Ellison S, Bagley SM, Fisher T, Glasgow L, Harris MTH, Huang TT, Holloway J, Lounsbury DW, Oga E, Asman K, Roberts SM, Sabounchi N, Surratt HL, Lines LM, Stadler HW, Taylor JL, Davis A. Local level of social inequity moderates implementation of evidence-based practices tailored to minoritized populations to reduce opioid overdose deaths. J Subst Use Addict Treat. 2026 Jan; 180:209828. PMID: 41175975.
Published on 9/20/2025Sandhu M, Thulien M, Eekhoudt CR, Friesen D, Moore E, Ignaszewski M, Bagley S, Motta-Ochoa R, Jenkins E, Fast D. RE-MAKING SELVES AND SOCIAL WORLDS: EXPERIENCES OF LIVE-IN SUBSTANCE USE TREATMENT AMONG ADOLESCENTS EXPERIENCING SOCIAL STRUCTURAL MARGINALIZATION IN VANCOUVER. SSM Qual Res Health. 2025 Dec; 8. PMID: 42004817.
Media Mentions
Published on 7/8/2026
Naloxone Is a Proven Fix for Overdoses. So Why Can’t Teens Access It?
Published on 9/8/2024
Deadlier drugs, younger addiction and no help in sight
Published on 4/11/2024
Q&A: How Pediatricians Can Counsel Patients and Parents on Overdose Prevention
Published on 1/25/2024
Effective Treatments for Opioid Use Disorder — Finding Recovery and Staying Safe
Published on 1/11/2024
Treating Opioid Use Disorder in General Practice — Diagnosis, Harm Reduction, and Medications
Published on 6/8/2023
Bill eyes on-campus safety net for students in recovery
Published on 5/31/2023
Bill Eyes On-Campus Safety Net For Students In Recovery
Published on 4/28/2023
Fentanyl deaths have spiked among U.S. children and teens
Published on 3/16/2023
Published on 2/9/2023
Community Is Critical in Stemming the Fentanyl Overdose Crisis
View full list of 29 media mentions.